Clinigen Group plc Annual Report and Accounts, and notice of AGM (2666D)
09 October 2018 - 5:00PM
UK Regulatory
TIDMCLIN
RNS Number : 2666D
Clinigen Group plc
09 October 2018
9 October 2018
Annual Report and Accounts, and notice of AGM
Clinigen Group plc (AIM: CLIN, 'Clinigen' or 'the Group'), the
global pharmaceuticals and services company, announces that its
Annual Report and Accounts for the year ended 30 June 2018 is now
available on the Group's website at www.clinigengroup.com.
Copies of the Annual Report and Accounts will be posted to
shareholders later today.
The Group will hold its Annual General Meeting ('AGM') on 8
November 2018 at 10.00am at Instinctif Partners' offices, 65
Gresham Street, London EC2V 7NQ. Shaun Chilton, Group Chief
Executive Officer, will give a presentation at the AGM. The slides
will be made available on the Group's website after the meeting. No
new material information will be provided.
- Ends -
Contact Details
Clinigen Group plc Tel: +44 (0) 1283 495
010
Peter Allen, Chairman
Matt Parrish, Head of Investor Relations
Numis Securities Limited Tel: +44 (0) 20 7260 1000
Michael Meade / Freddie Barnfield (Nominated
Adviser)
James Black / Tom Ballard (Corporate
Broking)
RBC Capital Markets - Joint Broker Tel: +44 (0) 20 7653 4000
Marcus Jackson / Elliot Thomas
Instinctif Partners Tel: +44 (0) 20 7457 2020
Melanie Toyne-Sewell / Alex Shaw / Deborah
Bell Email: clinigen@instinctif.com
About Clinigen Group
Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and
services company with a unique combination of businesses focused on
providing ethical access to medicines. Its mission is to deliver
the right medicine to the right patient at the right time through
three areas of global medicine supply; clinical trial, unlicensed
and licensed medicines. Clinigen acquired Quantum Pharma in
November 2017.
For more information, please visit www.clinigengroup.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCFSMSAAFASEIS
(END) Dow Jones Newswires
October 09, 2018 02:00 ET (06:00 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Apr 2024 to May 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Clinigen Group Plc (London Stock Exchange): 0 recent articles
More Clinigen Group News Articles